A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study. - Bender, David; Sill, Michael W.; Lankes, Heather A.; Reyes, Henry D.; Darus, Christopher J.; Delmore, James E.; Rotmensch, Jacob; Gray, Heidi J.; Mannel, Robert S.; Schilder, Jeanne M.; Hunter, Mark I.; McCourt, Carolyn K.; et al. (Gynecologic Oncology, 2015)